R-ループ駆動分子サブタイプは,子宮体内膜がんにおける予後および免疫遺伝学的特徴を明らかにします
1Department of Gynecology, Guangzhou No.12 People's Hospital, Guangdong 510700, China.
Computational biology and chemistry
|February 13, 2026
まとめ
R-ループ活性とCSDE1発現は,子宮内膜がん (UCEC) の不良結果と関連しています. CSDE1を標的にすることは,UCEC患者にとって,ゲノム不安定性と免疫抑制を統合した新しい治療戦略を提供することができる.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- ゲノミクスゲノミクスとは
背景:
- Rループは,3鎖の核酸構造で,ゲノムの不安定性と癌の進行に関与しています.
- 子宮内膜がん (UCEC) のRループの予後的意義とメカニズム的役割は十分に理解されていません.
研究 の 目的:
- UCECにおけるRループ活動とCSDE1の予後的意義とメカニズム的役割を調査する.
- R-ループ遺伝子とCSDE1.1に基づいたUCECの予後モデルを開発する.
主な方法:
- TCGAからのUCECデータのマルチオミクス分析,トランスクリプトミクス,臨床,変異,空間データを含む.
- 予測モデリング,生存分析,微分発現,CNVプロファイリング,変異比較,単細胞と空間トランスクリプトミクス.
- CSDE1の役割を評価するための in vivo および in vitro 機能実験.
主要な成果:
- R-ループの活性が上昇すると,UCECの進行段階,高グレード,低生存率と相関する.
- R-ループ遺伝子に基づく予後モデルは,高い予測精度を示し,CSDE1がトップの予測遺伝子でした.
- CSDE1+線維芽細胞は,SPP1経路を通じて免疫細胞と通信し,Rループの蓄積とDNAの損傷を減らすことにより,増殖と移住を促進します.
結論:
- R-ループ活動とCSDE1発現は,UCECにおけるゲノム不安定性,免疫抑制,およびストロマの改造を含む分子プログラムを定義する.
- この発見は,子宮内膜がんにおけるCSDE1の階層化された予後と治療的標的化を支持する.
関連する概念動画
Uterine Tubes
2.6K
The uterine or fallopian tubes function as the conduit through which oocytes travel from the ovaries to the uterus. Each fallopian tube measures approximately 10 to 13 cm long and is anatomically divided into the infundibulum, ampulla, isthmus, and interstitial part (or intramural segment). The infundibulum is characterized by its funnel shape and features extensions called fimbriae which reach towards the peritoneal cavity. These fimbriae play a critical role during ovulation as they extend...
2.6K
Adrenergic Receptors: ɑ Subtype
3.0K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.0K
Adrenergic Receptors: β Subtype
3.9K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.9K
Feedback Loops
64.8K
In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
64.8K
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Toxidromes: Clinical Features
17
Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
17


